Speakers

Expand/Collapse

Charles Makin
Global Head, Medical Health Outcomes
Biogen

Day One

Wednesday, October 27

9:15 am | The 10-Year Journey of Real-World Evidence (RWE) in Pharma & Beyond, & Building for the Next 10 Years

Kraig Kinchen
Senior Director, Center of Expertise, Global Patient Outcomes & Real World Evidence
Eli Lilly

Day One

Wednesday, October 27

2:30 pm | Demonstrating the Value of Real-World Evidence to Clinical Colleagues

Day Two

Thursday, October 28

12:30 pm | Roundtable: Turning Your RWE into Actionable Insights & Value Propositions For Patients & Payors

Kelly Zou
Head of Global Medical Analytics & Real World Evidence
Viatris

Day One

Wednesday, October 27

4:30 pm | Chair’s Closing Remarks

9:00 am | Chair’s Opening Remarks

Day Two

Thursday, October 28

3:15 pm | Chair’s Closing Remarks

11:30 am | Incorporating Real World Evidence to Drive Patient Outcomes Research

9:15 am | Panel Discussion: Reviewing Best Practice When Analyzing Real World Data

9:00 am | Chair’s Opening Remarks

Robertino Mera-Giler
Head Biostatistics, Epidemiology, RWE
Freenome Inc.

Day Two

Thursday, October 28

2:45 pm | Designing Synthetic Arm Trials Using Real World Evidence

Bindu Kalesan
Chief Executive Officer
Tury Sciences

Day One

Wednesday, October 27

1:30 pm | Utilizing Real-World Evidence to Gain a Greater Understanding of Patient Populations

Paul Petraro
Executive Director, Real World Evidence Analytic Centre of Excellence
Boehringer Ingelheim

Day One

Wednesday, October 27

11:15 am | Panel Discussion: Understanding the Data Quality Required

9:45 am | Reimagining Your Clinical Trial by Embracing Real-World Data

Eric Sarpong
Director Real World Data Analytics & Innovation, Center for Observational & Real World Evidence
Merck

Day Two

Thursday, October 28

10:30 am | Statistical, Econometrics Methods & Techniques for the Analysis of RWE & RWD

9:15 am | Panel Discussion: Reviewing Best Practice When Analyzing Real World Data

Lee Severson
Global Regulatory Lead, Global Product Strategy
CSL Behring

Day Two

Thursday, October 28

9:15 am | Panel Discussion: Reviewing Best Practice When Analyzing Real World Data

Angela Dobes
Vice President, IBD Plexus
Crohn’s & Colitis Foundation

Day One

Wednesday, October 27

4:00 pm | Partnering to Democratize Data & Accelerate Research

Lina Titievsky
Senior Director, RWE
Vertex Pharmaceuticals

Stuart Turner
Executive Director RWE & Data Science
Novartis

Day Two

Thursday, October 28

2:15 pm | Utilizing RWE in Breast Cancer Treatment Research

12:30 pm | Roundtable: Turning Your RWE into Actionable Insights & Value Propositions For Patients & Payors

Stuart McCully
CSO
Real-World Research Ltd.

WORKSHOP A: Adapting to Survive the Changing Climate of the Real-World Research Regulatory Environment 

Tuesday, October 26, 2021 - 10.00 - 12:30 EDT

Samantha St. Laurent
Director, Oncology Cell & Gene Therapy, Value Evidence & Outcomes
GSK

Day One

Wednesday, October 27

3:30 pm | Assessing the Value of Natural Language Processing

Anand Chokkalingam PhD
Executive Director - Real World Evidence
Gilead Sciences

Day One

Wednesday, October 27

10:15 am | Generating Real World Evidence for COVID-19 Treatments During a Global Pandemic

Yanni Hao
Executive Director, RWE & Data Science
Novartis

Day One

Wednesday, October 27

12:00 pm | Using RWD External Control to Emulate a Target Trial When a Randomized Trial is Not Available: Methodology & Regulatory Engagement in Cell & Gene Therapy

Dr. Rachele Hendricks- Sturrup
Research Director, Real World Evidence
Duke-Margolis Center for Health Policy

WORKSHOP B: RWE Applications 2.0 through Federated Machine Learning

Tuesday, October 26, 2021 - 13:30 - 16:00 EDT

L. Allen Kindman MD. FACC
Vice President, Protocol, Patient and Site Feasibility, Applied Data Science Center
IQVIA

Day One

Wednesday, October 27

2:00 pm | Using Real World Data to Promote Diversity and Inclusivity in Clinical Trials

Day Two

Thursday, October 28

12:30 pm | Roundtable: Turning Your RWE into Actionable Insights & Value Propositions For Patients & Payors

Mohamed Sharaf
EMEA Medical Program Lead
Janssen

Day Two

Thursday, October 28

12:00 pm | Using New Models for RWE in Post-Approval Activities

Jolyon Fairburn-Beech
Director, Real World Evidence Strategic Partnerships
GSK

Day One

Wednesday, October 27

11:15 am | Panel Discussion: Understanding the Data Quality Required

Richard Gliklich, MD
Chief Executive Officer
OM1, Inc

Day Two

Thursday, October 28

10:00 am | "Re-Usable" RWD Networks for Registries, Prospective Research, and Post Marketing Commitments

Dr. Sara Jordan
Senior Researcher, Artificial Intelligence and Ethics
Future of Privacy Forum

Russell Joyce
Director & Principal Consultant
Heath Barrowcliff Consulting